COVID-19 Resources
The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
Under construction – Building underway at the IDM
To make space for the growing staff complement at the IDM new construction has commenced.
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical Research
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
IDM Capacity Building
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.

University accredited research institute | Tackling diseases of importance in Africa | Developing people | Impacting health policy and practice

Home > Home


Sunday, 20 June 2021
Genetic determinants of rheumatic heart disease risk in black Africans identified

A pan-African study led by researchers at the University of Cape Town (UCT) has identified the genetic determinants of rheumatic heart disease (RHD) risk in black Africans.

Publication Date:
Fri, 11 Jun 2021 - 14:15
Missing targets to end HIV in children, a global failure

In light of missing paediatric HIV targets for 2020 by “a significant distance”, Professor Linda-Gail Bekker (director of the Desmond Tutu HIV Centre at the University of Cape Town) and Professor Kaymarlin Govender (research director at The Health Economics and HIV and AIDS Research Division at the University of KwaZulu-Natal), have called on governments to review their national strategies and commit resources to three key paediatric HIV issues.

Publication Date:
Fri, 11 Jun 2021 - 14:15
The Sisonke trial: Eight lessons for the nationwide vaccine roll-out

In a recent piece published by Bhekisisa - Centre for Health Journalism, Professor Linda-Gail Bekker, director of the Desmond Tutu HIV Centre at the University of Cape Town’s (UCT) Institute of Infectious Disease and Molecular Medicine, and Associate Professor Lara Fairall, director of the Knowledge Translation Unit at UCT, join representatives from various organisations to reflect on valuable lessons learnt from the Sisonke programme.

Publication Date:
Fri, 11 Jun 2021 - 10:00
Trial of potentially variant-proof vaccine ongoing in Western Cape

It’s been more than three months since University of Cape Town (UCT) researchers began the Phase 1 clinical trial of the hAd5 T-cell COVID-19 vaccine candidate. In this article by Spotlight, Professor Graeme Meintjes, the second chair in the Department of Medicine at UCT, the lead on the Wellcome Centre for Infectious Diseases Research in Africa’s Clinical Research Platform and a co-investigator on the trial, provides an update.

Publication Date:
Wed, 09 Jun 2021 - 10:30